ArticleInflammopharmacology2026
Anti-inflammatory approach of Polypodium vulgare roots by downregulation of pro-inflammatory cytokines in complete Freund's adjuvant-induced arthritis rats.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPolypodium vulgare Linn, roots commonly used in traditional Unani medicine, has been employed to treat ailments. Despite its extensive traditional use, particularly for inflammatory conditions like arthritis, has not been fully explored. AIM OF STUDY: The study aimed to evaluate the anti-inflammatory and anti-lipoxygenase effects of a 70% ethanolic extract of Polypodium. vulgare (P. vulgare) (HEPV) roots in a complete Freund's adjuvant (CFA)-induced arthritis rat model. MATERIALS AND
methodsPhytochemical presence was confirmed through preliminary analysis and GC-MS. Various assays, including 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) antioxidant potential, lipoxygenase inhibition, Human red blood cells membrane stabilization, and protein denaturation, were conducted. The anti-arthritic effects were evaluated in Wistar albino rats using a CFA-induced arthritis model, alongside its impact on blood parameters and pro-inflammatory cytokine mRNA expression (TNF-α and IL-6) through qRT-PCR.
resultsHEPV demonstrated antioxidant effect accompanied by an 50% inhibitory concentration (IC
conclusionThe study provides a preclinical basis for the anti-inflammatory and anti-arthritic potential of P. vulgare, warranting further toxicological and pharmacokinetic studies to confirm its therapeutic benefits in human.
Indexed as
Identifiers
42726436What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.